聯絡信息

職稱
副教授
辦公室
(辦公室) E12-4007
/(實驗室) N22-2002
電話
(辦公室) +853 8822 4988
/ (實驗室) +853 8822 2917/2918
傳真
+853 8822 2314
諮詢時間
星期一、四 11:30 – 12:30
教學
研究團隊
Education | |
PhD | University of Oxford (1996) |
MPhil | Hong Kong Polytechnic University (1992) |
BSc | Hong Kong Baptist College (1990) |
Positions | |
2013 – Present | Associate Professor, Faculty of Health Sciences, University of Macau |
2011 – 2012 | DMPK Design Leader, AstraZeneca |
2004 – 2011 | Associate Principal Scientist, AstraZeneca |
2001 – 2004 | Senior Scientist, AstraZenenca |
1996 – 2001 | Research Chemist, Sirius Analytical Ltd. |
Research Interests |
|
Representative Publications |
|
Full Publications List |
Research Grants | |
2020 – 2022 | Development of anticancer dichloroacetophenones through the inhibition of pyruvate dehydrogenase kinase 1, MOP 749,500 |
2018 – 2021 | Development of metabolic inhibitor for the treatment of non-small-cell lung carcinoma, MOP 1,460,000 |
2017 – 2020 | Novel Multi-targeting compounds for the treatment of Alzheimer´s disease, MOP 540,000 |
2015 – 2018 | Combination treatment with arginine depleting enzyme and metabolic inhibitor in preclinical cancer models, MOP 1,500,000 |
2014 – 2017 | Preclinical optimization of Aβ peptides aggregation inhibitors as potential drug candidates for the treatment of Alzheimer’s disease, MOP 1,456,000 |
2013 – 2015 | A study of the interactions between vancomycin, nafcillin and biomimetic artificial membranes, MOP 125,000 |
Patents |
|
Awards | |
2009 | AstraZeneca Regional Innovation Award |
2008 | AstraZeneca Publication Award |
Professional Recognition | |
2013 | Editor-in-chief, ADMET & DMPK (Scopus and ESCI indexed open access journal) |
2009 | AstraZeneca Regional Innovation Award (for the contribution to a discovery project using a pro-drug delivery approach) |
2008 | AstraZeneca Publication Award (Cancer and Infection Chemistry) |
2004 | Fellow of the Royal Society of Chemistry, UK |
1999 | Chartered Chemist and member of the Royal Society of Chemistry, UK |